Anti-HIV-1 antibody avidity is correlated with clinical status in infected children

Pediatric AIDS and HIV Infection

Volumn 7, Issue 1, 1996, Pages 14-19

  Sciascia, Concetta ^a   Palomba, Elvia ^a   Gay, Vincenzo ^b   Tovo, Pier Angelo ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE;

EID: 0029940007     PISSN: 10455418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tovo PA, de Martino M, Gabiano C, et al., Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992:339:1249-53.
2. Pizzo PA, Wilfert CM, and the Pédiatrie AIDS Siena Workshop II. Markers and determinants of disease progression in children with HIV infection. J Acquir Immune Defic Syndr Hum Retr 1995:8:30-44.
3. Centers for Disease Control and Prevention, 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994;43RR-12.
4. Saitta M, Gaido F, Palomba E, et al., Reduced immunoglobulin kappa/lambda light chain ratio in perinatally infected children. Pediatr AIDS HIV Infect: Fetus Adolesc 1994;5:344-9.
5. Krasinsky K, Borkowsky W, Measles and measles immunity in children infected with human immunodeficiency virus. JAMA 1989:261:2512-6.
6. Rutstein RM, Rudy B, Codispoti C, Watson B, Response to hepatitis B immunisation by infants exposed to HIV. AIDS 1994;8: 1281-4.
7. Ljunggren K, Moschese V, Broliden PA, et al., Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children bom to human immunodeficiency virus-infected mothers. J Infect Dis 1990:161:198-202.
8. Lal RB, Heiba IM, Dhawan RR, et al., IgG subclass responses to human immunodeficiency virus-1 antigen: lack of IgG2 response to gp41 correlates with clinical manifestations of disease. Clin Immunol Immunopathol 1991:58:267-77.
9. Robert-Guroff M, Roilides E, Muldoon R, et al., Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value. J Infect Dis 1993:167:538-6.
10. Broliden K, Sievers E, Tovo PA, et al.. Antibody-dependent cellular cytotoxicity and neutralising activity in sera of HIV-1-infected mothers and their children. Clin Exp Immunol 1993;93: 56-64.
11. Simon F, Rahimy C, Krivine M, et al., Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection. J Acquir Immune Defic Syndr 1993;6:201-7.
12. Palomba E, Gay V, de Martino M, et al., Early diagnosis of human immunodeficiency virus infection in infants by detection of free and complexed p24 antigen. J Infect Dis 1992; 165:394-5.
13. Rossi P, Moschese V, Broliden PA, et al., Presence of antibodies to HIV-1 gp!20 env epitopes correlates with uninfected status of children born to seropositive mothers. Proc Natl Acad Sei USA 1989:86:8055-8.
14. Erb P, Krauchi S, Burgin D, et al, Quantitative anti-p24 determinations can predict the risk of vertical transmission. J Acquir Immune Defic Syndr 1994:7:261-1
15. Markham RB, Coberly J, Ruff AJ, et al. Maternal IgGl and IgA antibody to V3 loop consensus sequence and maternal-infant HIV1 transmission. Lancet 1994:343:390-1.
16. Mann DL. Hamlin-Green G, Willoughby A, et al., Immunoglobulin class and subclass antibodies to HIV proteins in maternal serum: association with perinatal transmission. J Acquir Immune DeficSyndr 1994;7:617-22.
17. Chalgerlegue D, O'Toole CM, Colvin BT, A longitudinal study of IgG antibody response to HIV pi7 gag protein in H1V-1 + patients with haemophilia: titre and avidity. Clin Exp Immunol 1993; 93:331-6.
18. IS. Wen YM. Duan SC, Howard CR. et al., The affinity of anti-HBc antibodies in acute and chronic hepatitis B infection. Clin Exp Immunol 1990;79:83-6.
19. Pantaleo G, Graziosi C, Fauci AS, The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993:328:327-35.
20. Clerici M, Shearer G, A TH1 -TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993:14:107-11.
21. Coombs RW, Collier AC, Allain JP, et al., Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;321: 1626-31.
22. Nishanian P, Huskins KR, Stehn S, et al., A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J Infect Dis 1990;162:21-8.
23. McDonnel KB, Chmiel JS, Poggensee L, et al.. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med 1991:89:706-12.
24. Morand-Jubert L, Costagliola D, Blundau H, et al., Predicting progression of HIV disease: Usefulness of acid-dissociated p24 antigen. J Acquir Immune Defic Syndr 1994;7:676-80.
25. Palomba E, Gay V, de Martine M, et al.. Sensitivity and specificity of complexed p24 antigen assay for early diagnosis of perinatal HIV-1 infection. AIDS 1993:7:1391-3.